Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jan 16:2023:1542785.
doi: 10.1155/2023/1542785. eCollection 2023.

HIV-Associated Vacuolar Myelopathy and HIV-Associated Neurocognitive Disorder as an Initial Presentation in HIV Infection

Md Asaduzzaman  1 , Atonu Das  1 , Sowmitra Das  2 , Mahfuza Khadija Shamma  2 , Abul Kalam Mohammed Shoab  2 , Biplob Kumar Roy  2
Affiliations
Case Reports

HIV-Associated Vacuolar Myelopathy and HIV-Associated Neurocognitive Disorder as an Initial Presentation in HIV Infection

Md Asaduzzaman et al. Case Rep Infect Dis. .

Abstract

Several neurological disorders have been described in HIV infection. Vacuolar myelopathy and neurocognitive disorders usually come at an advanced stage of the disease process. Here, we present a case where these features constitute the presenting complaints. Both of these conditions improved significantly following the start of HAART. We believe this clinical pathway can be a good learning point for the clinician.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
MRI brain: (a) T1 axial view and (b) T2 coronal view, showing generalized brain atrophy.
Figure 2
Figure 2
MRI cervical and thoracic spine: (a, b) T2 sagittal and (c) axial view, showing no abnormality.
See this image and copyright information in PMC

References

    1. Pan G. J. D., Glass J. D., McArthur J. C. Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-basedcase-control study: an autopsy-basedcase-control study. Neurology . 1994;44(11):2159–2164. doi: 10.1212/wnl.44.11.2159. - DOI - PubMed
    1. Di Rocco A., Simpson D. M. AIDS-associated vacuolar myelopathy. AIDS Patient Care and STDs . 1998;12(6):457–461. doi: 10.1089/apc.1998.12.457. - DOI - PubMed
    1. Antinori A., Arendt G., Becker J. T., et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology . 2007;69(18):1789–1799. doi: 10.1212/01.WNL.0000287431.88658.8b. - DOI - PMC - PubMed
    1. Clifford D. B., Ances B. M. HIV-associated neurocognitive disorder. The Lancet Infectious Diseases . 2013;13(11):976–986. doi: 10.1016/S1473-3099(13)70269-X. - DOI - PMC - PubMed
    1. Akagi K., Yamamoto K., Umemura A., et al. Human immunodeficiency virus-associated vacuolar encephalomyelopathy with granulomatous-lymphocytic interstitial lung disease improved after antiretroviral therapy: a case report. AIDS Research and Therapy . 2020;17(1):p. 38. doi: 10.1186/s12981-020-00295-y. - DOI - PMC - PubMed

Publication types

LinkOut - more resources